Rare Bleeding Disorders
Other Therapy Areas
Explore diabetes
Explore obesity
Explore rare bleeding disorders
Explore growth-related disorders
Explore hormone replacement therapy
Medical Information | Non-US Health Care Professionals
Account Settings
Communication Preferences
Sign Out
Sign In | Create Account
  • Rare Bleeding Disorders Home
    • Products
      Our Treatments How to Order Trial Prescriptions Recombinant Manufacturing
    • Professional Resources
      Product Resources Library Contact Your Representative
    • Disease Education
      Clinical Education Library Congenital Hemophilia with Inhibitors Acquired Hemophilia Glanzmann's Thrombasthenia Interactive Joint Bleed Model
    • Treatment Guidelines
      MASAC Guidelines WFH Guidelines
    • Additional Resources
      Organizations & Conferences
    • Product Education
      Product Education Materials
    • Disease Education
      Disease Education Resources
    • Access & Affordability
      Prescription Savings & Insurance Support
  • Sign In
    Create Account
    • Account Settings
    • Communication Preferences
    • Sign Out
    Other Therapy Areas
    Medical Information
    Non-US Health Care Professionals

Emergency Medicine

We’re here to help, with information on hemophilia and rare bleeding disorders that fits your needs

We’re here to help, with information on hemophilia and rare bleeding disorders that fits your needs

Learn about a potential treatment

Explore now

Actor portrayal

Quick links

Acquired hemophilia clinical pathway
Congenital hemophilia with inhibitors clinical pathway

Professional education recommended for you

Congenital hemophilia with inhibitors

Congenital hemophilia with inhibitors

Learn about the occurrence and risk factors for inhibitors, and the importance of managing emergent bleeds in patients with hemophilia A or B with inhibitors.

Begin here
See patient case study
Warning signs icon

Understanding acquired hemophilia

Acquired hemophilia (AH) appears spontaneously in people who were not born with hemophilia. Learn the facts and review the symptoms of this rare condition.

Explore AH
See patient case study
(23:18)
Recognizing Rare Bleeding Disorders
Recognizing Rare Bleeding Disorders
23:18
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
Recognizing Rare Bleeding Disorders
Dr. Miguel Escobar discusses how hematologists and oncologists can diagnose and treat unexplained bleeds in patients with acquired hemophilia.
Listen

Product resources library

Resources library icon

Get the latest information on treatments for hemophilia and rare bleeding disorders, approaches to treating these diseases, and clinical study results.

Browse resources

MASAC Guidelines

Guidelines icon

Review MASAC guidance for emergency department staff who may see patients present with a rare bleeding disorder.

Find out more

MASAC= Medical and Scientific Advisory Council of the National Hemophilia Foundation

Have questions? Contact your local Novo Nordisk Representative

Rare Bleeding Disorders
Other Therapy Areas
Explore diabetes
Explore obesity
Explore rare bleeding disorders
Explore growth-related disorders
Explore hormone replacement therapy
  • Rare Bleeding Disorders Home
  • Product Information
    Products
    • Our Treatments
      How to Order
      Trial Prescriptions
      Recombinant Manufacturing
    Professional Resources
    • Product Resources Library
      Contact Your Representative
  • Professional Education
    Disease Education
    • Clinical Education Library
      Congenital Hemophilia with Inhibitors
      Acquired Hemophilia
      Glanzmann's Thrombasthenia
      Interactive Joint Bleed Model
    Treatment Guidelines
    • MASAC Guidelines
      WFH Guidelines
    Additional Resources
    • Organizations & Conferences
  • Patient Support
    Product Education
    • Product Education Materials
    Disease Education
    • Disease Education Resources
    Access & Affordability
    • Prescription Savings & Insurance Support

novoMEDLINK™ is a trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to pro.novonordisk.com.

Legal Notice | Privacy Policy | Cookie Policy | Contact Us |
novonordisk-us.com    
© 2021 Novo Nordisk All rights reserved.  US21HCP00068 October 2021

Quick links

Trial prescription programs

Patient access and affordability options

MASAC treatment guidelines

Patient educational materials